Overview

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The DISCO-RLS Trial is a randomized controlled trial to determine the safety and efficacy of pharmacologic therapy (ropinirole versus placebo and gabapentin versus placebo) for the treatment of Restless Legs Syndrome in patients with End Stage Renal Disease requiring hemodialysis.
Phase:
Phase 3
Details
Lead Sponsor:
Population Health Research Institute
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Ropinirole